| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/06/2011 | CN102002069A Preparation method of dicyclic intermediate for synthesizing carbapenem side chains and application thereof |
| 04/06/2011 | CN102002057A Preparation method for 3,4-ethylene dioxythiophene-2,5-dicarboxylic acid dimethyl ester |
| 04/06/2011 | CN102002056A Method for preparing intermediate of prasugrel |
| 04/06/2011 | CN102002055A Clean synthesis method for 3,4-ethylenedioxythiophene |
| 04/06/2011 | CN102002054A Pyrazole type compound and preparation method and application thereof |
| 04/06/2011 | CN102002053A Tetrahydro thienopyridine derivative for treating |
| 04/06/2011 | CN102002037A Triphenylamine compound and application thereof |
| 04/05/2011 | US7919071 Contrast agent |
| 04/05/2011 | CA2515730C Pyrrolidinohydrochinazolines |
| 03/31/2011 | WO2011037128A1 Nitrogen-containing heterocyclic compound and salt thereof, and bactericide for agricultural and horticultural use |
| 03/31/2011 | WO2011036866A1 Organic thin-film transistor |
| 03/31/2011 | WO2011036284A1 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | WO2011036128A1 Heterocyclic antiviral compounds |
| 03/31/2011 | WO2011035416A1 Hsp90 modulating compounds, compositions, methods and uses |
| 03/31/2011 | US20110077394 Light-driven rotary molecular motors |
| 03/31/2011 | US20110077389 Novel Reagents Utilizing A Serinol Scaffold For Labeling Synthetic Oligonucleotides |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077240 Inhibitors of protein tyrosine kinase activity |
| 03/31/2011 | US20110077154 Substituted pyridin-4-yl-methyl sulfonamides as fungicides |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110074491 Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device |
| 03/31/2011 | DE102009043342A1 Stoffe für selbstorganisierte Träger zur kontrollierten Freisetzung eines Wirkstoffs Materials for self-organized support for the controlled release of a drug |
| 03/31/2011 | CA2774807A1 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | CA2768523A1 Heterocyclic antiviral compounds |
| 03/30/2011 | EP2301932A1 Novel ligands for sensitizing dyes of dye-sensitized solar cells |
| 03/30/2011 | EP2301926A1 Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound |
| 03/30/2011 | EP2301921A1 Polycyclic compound and organic electroluminescent device using the same |
| 03/30/2011 | EP2300480A2 Process for the preparation of clopidogrel hydrogen sulfate crystalline form i |
| 03/30/2011 | EP2300471A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides |
| 03/30/2011 | EP1558586B1 Inhibitors of akt activity |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/30/2011 | CN101998853A Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators |
| 03/30/2011 | CN101993447A Method for synthesizing Prasugrel artificially |
| 03/30/2011 | CN101245072B Intermediate for producing prasugrel and producing method thereof |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7914905 π-conjugated aromatic ring-containing compound and organic electroluminescent device |
| 03/24/2011 | WO2011034962A2 Compounds that modulate intracellular calcium |
| 03/24/2011 | WO2010115184A3 Hydroxythienoquinolones and related compounds as anti-infective agents |
| 03/24/2011 | US20110071170 Tricyclic pyrazolopyrimidine derivatives |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110070190 Heterocyclic antiviral compounds |
| 03/24/2011 | CA2774367A1 Novel compounds and therapeutic use thereof for protein kinase inhibition |
| 03/24/2011 | CA2774266A1 Novel tricyclic protein kinase modulators |
| 03/23/2011 | EP2298777A2 Method for preparing clopidogrel and its derivatives |
| 03/23/2011 | EP2298776A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 03/23/2011 | EP2298729A1 Method of producing optically active amino acid derivative |
| 03/23/2011 | EP2298312A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
| 03/23/2011 | EP2297748A1 Poly(5,5'bis(thiophen-2-yl)-benzo[2,1-b;3,4-b']dithiophene) and its use as high performance solution processable semiconducting polymer |
| 03/23/2011 | EP2297150A1 Substituted quinazolines as blood platelet lowering agents |
| 03/23/2011 | EP2297146A1 Substituted quinazolines |
| 03/23/2011 | EP2297114A2 Heterocyclic compound and use thereof |
| 03/23/2011 | EP2102214B1 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| 03/23/2011 | EP1851228B1 Pyrimidothiophene compounds having hsp90 inhibitory activity |
| 03/23/2011 | CN101987854A Preparation method of clopidogrel and salts thereof |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101379067B Thieno-pyridine derivatives as MEK inhibitors |
| 03/23/2011 | CN101245073B Medicine intermediate and preparation method thereof |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/17/2011 | WO2011030918A1 Leaving substituent-containing compound, organic semiconductor material, organic semiconductor film containing the material, organic electronic device containing the film, method for producing film-like product, pi-electron conjugated compound and method for producing the pi-electron conjugated compound |
| 03/17/2011 | WO2011029456A1 A process for making prasugrel and its intermediates |
| 03/17/2011 | WO2011029279A1 Fused heteroaryl compounds, preparation method and use thereof |
| 03/17/2011 | WO2010108058A3 Small molecule inhibitors of dusp6 and uses therefor |
| 03/17/2011 | US20110065895 Fused ring compound, method for producing the same, polymer, organic thin film containing the compound and/or polymer, and organic thin film device and organic thin film transistor each comprising the organic thin film |
| 03/17/2011 | US20110065724 Compounds that modulate intracellular calcium |
| 03/17/2011 | US20110065698 Novel protein kinase modulators |
| 03/17/2011 | US20110065695 Use of aminodihydrothiazines for the treatment or prevention of diabetes |
| 03/17/2011 | US20110065690 Compositions and methods for treatment of leukemia |
| 03/17/2011 | US20110065164 Double-labelling agents based on vinyl sulphone |
| 03/17/2011 | US20110062426 Substituted oligo- or polythiophenes |
| 03/17/2011 | CA2773848A1 Pi3 kinase inhibitors and uses thereof |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | CN101985451A Preparation method of prasugrel intermediate |
| 03/16/2011 | CN101985450A 普拉格雷盐及其制备方法 Prasugrel salt and its preparation method |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906642 Isopropanol water solvate of olanzapine |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/10/2011 | WO2011029001A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011027988A2 Novel polymorphic form of prasugrel-hydrogen sulfate |
| 03/10/2011 | WO2011027849A1 Heterocyclic compound |
| 03/10/2011 | WO2011027805A1 Therapeutic agent for mood disorders |
| 03/10/2011 | WO2010131855A3 Compound containing a 5-membered heterocycle and organic light-emitting diode using same, and terminal for same |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059018 Covalently binding imaging probes |
| 03/10/2011 | CA2772625A1 Compounds as tyrosine kinase modulators |
| 03/09/2011 | EP2292624A1 Process for the purification of olanzapine |
| 03/09/2011 | EP2292586A2 Photoelectric conversion material, film containing the material, photoelectric conversion device, production method thereof, photosensor, imaging device and their use methods |
| 03/09/2011 | EP2176269B1 A method of manufacturing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7- tetrahydrothieno[3,2-c]pyridin-2-yl acetate (prasugrel) |
| 03/09/2011 | EP2109615B1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 03/09/2011 | EP1656381B1 Crystallisation of solid forms of clopidogrel addition salts |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902203 Polymerase inhibitors; viricides; hepatitis c virus; immunology moderator; antiinflammatory agents; cirrhosis; liver disorders |
| 03/03/2011 | WO2011025947A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2011025940A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2011025859A1 Condensed quinolines as protein kinase modulators |
| 03/03/2011 | WO2011024871A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011024869A1 Fused heterocyclic ring derivative and use thereof |